Built for participants. Licensed for institutions.
ResearchClaro guides are designed for participants. Licensing allows your organization to distribute them at scale while keeping the content independent, plain-language, and participant-first.
Why It Matters
Participant confusion
has a real cost
for your study.
01
Participant Dropout Is a Leading Cause of Trial Delay
High attrition rates inflate timelines and costs, and often trace back to participants who didn't fully understand their commitment at enrollment. Clear, plain-language education at the start reduces dropout by setting honest expectations.
↓ Attrition risk
02
Informed Consent Is a Regulatory and Ethical Flashpoint
IRBs and the FDA scrutinize whether participants genuinely understood the consent process — not just whether they signed a form. A third-party, plain-language supplement strengthens your consent documentation and demonstrates good faith effort.
↑ IRB confidence
Clinical research depends on informed, engaged participants. When people don't fully understand what they're agreeing to or feel overwhelmed by the consent process, they drop out, decline enrollment, or disengage entirely. ResearchClaro guides address this directly, before it becomes a problem for your trial.
03
FDA Diversity Guidance Is Now a Compliance Priority
The FDA's 2024 diversity action plan guidance requires sponsors to actively support enrollment from underrepresented communities. A bilingual, culturally accessible guide written by someone with hands-on community engagement experience is a concrete, documentable step toward that goal.
↑ Diversity enrollment
Single Study
What We Offer
Study license
Best for: CROs testing the guide on a single study
Study license
$500–$1,500
one-time · per study
One trial or study, one site
Distribute to participants only
ResearchClaro branding retained
PDF format, no edits
Most Popular
Institutional license
Best for: Mid-size pharma, academic medical centers
Institutional license
$3,000–$6,000
per year · unlimited internal use
Unlimited studies & sites
Digital + print distribution
ResearchClaro branding retained
Annual renewal option
Usage report at renewal
Custom
Enterprise / co-brand
Best for: Large pharma, global CROs, health systems
Enterprise / co-brand
$10,000+
per year · negotiated
Co-branded or white-labeled
Minor content customization
Editable source files
Multi-language rights (add-on)
Dedicated renewal support
Request a license
Always included: Copyright notice on all distributed copies
Never included: Resale rights or sublicensing to third parties
Optional add-on: Translation rights (+$1,500–$3,000/language)